Healthleap Raises $38M to Spot Undiagnosed Hospital Patients With AI

Overview

Healthleap, a health technology startup leveraging artificial intelligence to detect undiagnosed conditions in hospitalized patients, has secured $38 million in new funding. The financing round was structured as a combination of an $8 million seed investment and a $30 million Series A extension.

The seed portion was co-led by prominent venture capital firms Sequoia Capital and First Round Capital. The larger Series A component was led by Hummingbird Ventures. The company has chosen not to disclose its current valuation following the close of this funding round.

Founded in South Africa in 2022 by siblings Jemima and Josiah Meyer, the company initially began as a clinical nutrition tool designed for dietitians. It has since pivoted to develop a broader AI platform that scans electronic health records to flag patients at risk of conditions such as malnutrition and delirium.

Market Impact and Performance

Healthleap’s platform is currently deployed across more than 50 hospitals globally, including major healthcare systems such as Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare. The startup reports a tenfold increase in revenue over the past year, although specific financial figures remain undisclosed.

The company operates on a contract model priced according to a hospital’s licensed bed count, typically spanning three years. It also employs an outcome-based pricing structure that ties compensation to measurable financial returns for the healthcare facility.

“To date, every customer has seen a 5x hard ROI or more, in some cases over 20x annual total ROI,” said Josiah Meyer.

At the Hospital of the University of Pennsylvania, the startup claims its malnutrition screening program generated an annualized financial impact of $23.8 million. This figure includes $6.3 million in additional reimbursements and $17.5 million derived from reduced hospital lengths of stay.

Malnutrition serves as a critical entry point for the technology because it is frequently overlooked in acute care settings. Research indicates that between 20% and 50% of hospital inpatients suffer from malnutrition, a condition linked to impaired wound healing, increased infection risks, longer recovery times, and higher mortality rates.

Technology and Clinical Approach

Healthleap integrates directly into hospital electronic health record systems to analyze patient data. The platform processes both structured data, such as lab results and vital signs, and unstructured data found in clinicians’ written notes. By using language models, the system identifies affirmative or negated mentions of clinical concepts like recent weight loss, poor appetite, and difficulty swallowing.

The software does not provide medical diagnoses. Instead, it generates risk scores and flags patients who may require closer clinical review. Each night, the algorithm analyzes every adult inpatient’s record, including medications, diet orders, and clinical trends.

“A patient’s chart holds two kinds of data. Labs, weights, and vital signs sit in structured fields, but the most telling signs sit in clinicians’ written notes,” explained Josiah Meyer.

Each morning, the platform updates a dashboard within the care team’s existing workflow, presenting risk scores and trend data for immediate attention. Beyond malnutrition, the company is actively validating programs to detect aspiration pneumonia, pressure ulcers, and readmission risks for congestive heart failure.

Strategic Expansion Plans

The newly raised capital will be allocated toward engineering, product development, sales, and customer success initiatives. Healthleap aims to expand its clinical coverage to include more than 40 major health conditions, building on its current focus areas.

Management also intends to extend the platform’s capabilities beyond inpatient settings. Future deployments are planned for outpatient clinics and home care environments, where early detection of deteriorating health can prevent emergency hospitalizations.

The company’s growth strategy relies heavily on demonstrating tangible return on investment to hospital administrators. By quantifying savings from shorter stays and improved reimbursement rates, Healthleap seeks to position its AI tools as essential infrastructure for modern healthcare finance and quality improvement.